Common Variation in the DIO2 Gene Predicts Baseline Psychological Well-Being and Response to Combination Thyroxine Plus Triiodothyronine Therapy in Hypothyroid Patients
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Introduction: Animal studies suggest that up to 80% of intracellular T3 in the brain is derived from circulating T4 by local deiodination. We hypothesized that in patients on T4 common variants in the deiodinase genes might influence baseline psychological well-being and any improvement on combined T4/T3 without necessarily affecting serum thyroid hormone levels. Methods: We analyzed common variants in the three deiodinase genes vs. baseline psychological morbidity and response to T4/T3 in 552 subjects on T4 from the Weston Area T4 T3 Study (WATTS). Primary outcome was improvement in psychological well-being assessed by the General Health Questionnaire 12 (GHQ-12). Results: The rarer CC genotype of the rs225014 polymorphism in the deiodinase 2 gene (DIO2) was present in 16% of the study population and was associated with worse baseline GHQ scores in patients on T4 (CC vs. TT genotype: 14.1 vs. 12.8, P = 0.03). In addition, this genotype showed greater improvement on T4/T3 therapy compared with T4 only by 2.3 GHQ points at 3 months and 1.4 at 12 months (P = 0.03 for repeated measures ANOVA). This polymorphism had no impact on circulating thyroid hormone levels. Conclusions: Our results require replication but suggest that commonly inherited variation in the DIO2 gene is associated both with impaired baseline psychological well-being on T4 and enhanced response to combination T4/T3 therapy, but did not affect serum thyroid hormone levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
The validity of the Hospital Anxiety and Depression Scale
Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00296-3 · Cited by 9,779 · cited 12×
“Each C allele was associated with a 49% increase in odds of being a HAD-D case (P 0.01) and as a result caseness was almost twice as great in subjects homozygous for the CC genotype as in subjects with the TT genotype (24 vs. 13%).”
BackgroundMethodInfluentialThe Validity of Two Versions of the GHQ in the WHO Study of Mental Illness in General Health Care
GOLDBERG, D. P., GATER, R., SARTORIUS, N., USTUN, T. B., PICCINELLI, M., GUREJE, O., & RUTTER, C. (1997) · Psychological Medicine · doi:10.1017/s0033291796004242 · Cited by 3,657 · cited 8×
“First Published Online February 3, 2009 For editorial see page 1521 Abbreviations: C, Cytosine; fT3, free T3; fT4, free T4; GHQ-12, General Health Questionnaire, 12-question version; HAD, Hospital Anxiety and Depression Scale questionnaire; SNP, single-nucleotide polymorphism; T, thymine; TSQ, thyroid symptom question…”
MethodInfluentialBianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514 · cited 12×
“However, when analyzed T T 1 2 3 11 12 13 14 15 16 17 18 TC 1 2 3 11 12 13 14 15 16 17 18 C C 1 2 3 11 12 13 14 15 16 17 18 B – TSQ *p = 0.03 T T 1 2 3 3.0 3.1 3.2 3.3 3.4 3.5 TC 1 2 3 3.0 3.1 3.2 3.3 3.4 3.5 C C 1 2 3 3.0 3.1 3.2 3.3 3.4 3.5 C – Satisfaction *p = 0.02 T T 1 2 3 9 10 11 12 13 14 15 T C 1 2 3 9 10 11 1…”
BackgroundMethodInfluentialSelf-citationBunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 1×
“However, although in the initial study of combination therapy (T4 and T3), patients treated with the combination appeared to have improved well-being (10), 10 subsequent larger studies failed to confirm this benefit (11–20) and in at least one case demonstrated a large and sustained placebo effect (18).”
BackgroundThyroid hormones, serotonin and mood: of synergy and significance in the adult brain
Bauer, M., Heinz, A., & Whybrow, P. C. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000963 · Cited by 370
Wekking, E. M., Appelhof, B. C., Fliers, E., Schene, A. H., Huyser, J., Tijssen, J. G. P., & Wiersinga, W. M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02025 · Cited by 299
Grozinsky-Glasberg, S., Fraser, A., Nahshoni, E., Weizman, A., & Leibovici, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0448 · Cited by 296 · cited 2×
“Metaanalysis of these trials (21) showed no benefit from combination therapy and a carefully controlled study of overreplacement with T4 also failed to show benefit (22).”
BackgroundEscobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287
Escobar-Morreale, H. F., del Rey, F. E., Obregón, M. J., & de Escobar, G. M. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641203 · Cited by 261 · cited 1×
“reported that it was not possible to normalize tissue levels of thyroid hormone (T4 and T3) by replacement with T4 alone (2, 3) or T3 alone (4).”
Background
Research works printed but not linked: 1
- Levitt, 2002, T4 plus T3 for hypothyroidism: a double-blind comparison with usual T4, 4
Cited by
Items 301–327 of 327
Гончарова, О. А. (2015) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.8.64.2014.77867
Göbel, A. (2020) · Zeitschrift für Neuropsychologie · doi:10.1024/1016-264x/a000285
Essentials of Thyroid Hormone Treatment in Differentiated Thyroid Cancer
Aydoğan, B. İ., & Gürsoy, A. (2021) · Nuclear Medicine Seminars · doi:10.4274/nts.galenos.2021.0002 · Cited by 1
Time to refresh thinking on the terminology and management of hypothyroidism?
Leese, G., & Soto‐Pedre, E. (2021) · Clinical Endocrinology · doi:10.1111/cen.14485
64 脳卒中片麻痺における,音刺激後の片脚挙上動作反応時間と歩行能力の関連性(神経系理学療法IV)
福井, 瑞., 久保田, 健., 伊藤, 俊., & 隈元, 庸. (2005) · Journal of the Japanese Physical Therapy Association
Newman, S. K., & Davies, T. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00120-1 · Cited by 1
Luíz, H. V., Manita, I., & Portugal, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_7
Osama, M., & Ahme, R. G. (2012) · InTech eBooks · doi:10.5772/30197
Disfunción tiroidea y síntomas neuropsiquiátricos: una relación descrita, pero poco conocida
Solís-Sáinz, J. C., Delgado-Ángeles, J. M., López, J. V. R., Robles‐Osorio, L., & Solís-Sáinz, J. C. (2022) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.21000014
Shames, R., & Wenzel, S. (2022) · Journal of Restorative Medicine · doi:10.14200/jrm.2022.0002 · Cited by 1
Deiodinase Type 3 Polymorphism (rs1190716) Affects Therapeutic Response to Levothyroxine
Mohmmed, A. H., Hoshi, B., & Jubair, S. (2022) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2022.04876 · Cited by 4
Dolia, P. B., & Dhanunjaya, Y. (2015) · JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES · doi:10.58739/jcbs/v05i4.4
Therapeutic use of triiodothyronine in hypothyroidism: Current status and the road ahead
Das, S. (2023) · Journal of Integrative Medicine and Research · doi:10.4103/jimr.jimr_7_23
Subclinical Hypothyroidism Diagnosis and Management in Primary Care settings
Elgharib, M. I. M., & Mokibel, M. A. K. (2023) · Scholars Journal of Dental Sciences · doi:10.36347/sjds.2023.v10i05.006
Endo, M. (2023) · Clinical Thyroidology · doi:10.1089/ct.2023;35.316-318
Quarde, A. (2023) · Wiley eBooks · doi:10.1002/9781119863564.ch2
Terapia dell’ipotiroidismo primitivo: un ormone o due ormoni?
Brigante, G., Ceccarini, G., Porcelli, T., Santini, F., Salvatore, D., Simoni, M., & Bartalena, L. (2024) · L Endocrinologo · doi:10.1007/s40619-024-01429-4
Bipolar Disorder and Endocrine Involvement: Hypothyroidism
Biswanath, R., & Hmar, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_93-1
Precision Thyroid Hormone Therapy for Hypothyroidism
Bianco, A. C., & Beltrão, F. E. D. L. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_24
Bipolar Disorder and Endocrine Involvement: Hypothyroidism
Biswanath, R., & Hmar, B. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_93
Duntas, L. H., & Feldt‐Rasmussen, U. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00365-4
Endocrine hypertension in 2025: how AI and multiomics are revolutionizing detection
Fuentes‐Mendoza, J. M., Concepción‐Zavaleta, M. J., Mendoza-Godoy, J. J., Aldave, J. E. Q., Morón-Siguas, J. C., & Paz‐Ibarra, J. (2026) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2026.2634025
Bing, Y., Liu, Y., Zhou, Z., Li, Y. W., Han, Y., Meng, G., & Jiang, Y. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261444838
Nagayama, Y., Tachibana, S., Fukuda, T., Tatsushima, D., Mori, Y., Shindo, H., Takahashi, H., Satoh, S., Nakashima, M., & Yamashita, H. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag220
Health-related quality of life in benign thyroid diseases assessed by ThyPRO
Sawicka‐Gutaj, N., Derwich-Rudowicz, A., Bromińska, B., Maciejewska, J., Nijakowski, K., Kozłowska, P., Adamczak, O., Rytelewski, Z., Kyriacou, A., & Ruchała, M. (2026) · Endocrine Connections · doi:10.1530/ec-26-0097
Altun, G., & Çiftel, E. (2026) · Medicina · doi:10.3390/medicina62102017
Metadata
- Authors
- Panicker, V., Saravanan, P., Vaidya, B., Evans, J., Hattersley, A. T., Frayling, T. M., & Dayan, C. M.
- Affiliations
- The University of Western Australia (AU)
- University of Bristol (GB)
- Royal Devon and Exeter Hospital (GB)
- University of Exeter (GB)
- Corresponding author
- Dayan, Colin M.
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2009-05-01
- Volume
- 94
- Issue
- 5
- Pages
- 1623-1629
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2059487357
- Cited by
- 327
- References
- 39
- Citations by year
- 2026: 9 · 2025: 12 · 2024: 10 · 2023: 23 · 2022: 27 · 2021: 23 · 2020: 15 · 2019: 25 · 2018: 22 · 2017: 21 · 2016: 25 · 2015: 22 · 2014: 19 · 2013: 21 · 2012: 21
- FWCI
- 12.34
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- deiodinase 2, triiodothyronine, thyroxine, hypothyroidism, combination thyroid hormone therapy, genetic polymorphism, psychological well-being, treatment response, GHQ-12, serum thyroid hormones
- MeSH terms
- Iodothyronine Deiodinase Type II, Adult, DNA, Female, Genotype, Health Status, Humans, Hypothyroidism, Iodide Peroxidase, Male, Polymorphism, Genetic, Predictive Value of Tests, Psychometrics, Surveys and Questionnaires, Thyroid Function Tests, Thyrotropin, Thyroxine, Triiodothyronine, Genetic Variation, Hormone Replacement Therapy, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.